Clinical trials in developing countries
Swissmedic’s role in protecting vulnerable participants
Report Public Eye (anciennement Déclaration de Berne), 2013
Switzerland has a central role to play in the respect of ethical norms for drug trials conducted in developing and emerging countries. However, the ethical controls carried out by the drug regulatory agency, Swissmedic, are clearly inadequate, as confirmed by an investigation conducted by Public Eye in Switzerland. The Swiss legislation itself has major gaps.